14 dicembre 2007 / 12:51 / tra 10 anni

Encysive sees Thelin sales of $10.5-$11.5 mln in 2007

Dec 14 (Reuters) - Encysive Pharmaceuticals Inc ENCY.O said it expects 2007 sales of its hypertension drug, Thelin, to be about $10.5 million to $11.5 million.

For 2008, it expects the drug’s sales to be about $40 million to $50 million.

The drug is approved in the European Union, Canada and Australia, the company said in a statement. (Reporting by Avishek Mishra in Bangalore; Editing by Vinu Pilakkott)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below